SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-069471
Filing Date
2021-03-04
Accepted
2021-03-04 16:06:03
Documents
3
Period of Report
2021-03-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d146113d8k.htm 8-K 25010
2 EX-99.1 d146113dex991.htm EX-99.1 18575
3 GRAPHIC g146113dsp5.jpg GRAPHIC 2898
  Complete submission text file 0001193125-21-069471.txt   49207
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 21714158
SIC: 2834 Pharmaceutical Preparations